Cargando…
Does Remdesivir maintain the race in the general treatment protocol of COVID-19?
Autores principales: | Thangaraju, Pugazhenthan, Velmurugan, Hemasri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884325/ https://www.ncbi.nlm.nih.gov/pubmed/35280619 http://dx.doi.org/10.4103/jfmpc.jfmpc_1552_21 |
Ejemplares similares
-
Diligence needed on treatment of primary multidrug-resistant pulmonary tuberculosis with concomitant COVID-19 infection
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022) -
Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023) -
Gestational diabetes: Unfolded area still a concern
por: Velmurugan, Hemasri, et al.
Publicado: (2023) -
Health strategy in South State of India – Towards older people
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023) -
Paediatric dosage ‘need of hours among family physicians/other speciality physicians’
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022)